Published in Proc Natl Acad Sci U S A on April 27, 2015
Transcriptome analysis of periodontitis-associated fibroblasts by CAGE sequencing identified DLX5 and RUNX2 long variant as novel regulators involved in periodontitis. Sci Rep (2016) 0.75
Reprogrammed Functional Brown Adipocytes Ameliorate Insulin Resistance and Dyslipidemia in Diet-Induced Obesity and Type 2 Diabetes. Stem Cell Reports (2015) 0.75
Direct lineage reprogramming via pioneer factors; a detour through developmental gene regulatory networks. Development (2016) 0.75
Regulation of pluripotency and differentiation by deubiquitinating enzymes. Cell Death Differ (2016) 0.75
Cellular Reprogramming Using Defined Factors and MicroRNAs. Stem Cells Int (2016) 0.75
Biscarbamate Cross-Linked Low-Molecular-Weight Polyethylenimine for Delivering Anti-chordin siRNA into Human Mesenchymal Stem Cells for Improving Bone Regeneration. Front Pharmacol (2017) 0.75
Directly reprogramming fibroblasts into adipogenic, neurogenic and hepatogenic differentiation lineages by defined factors. Exp Ther Med (2017) 0.75
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell (2006) 120.51
Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell (2007) 101.42
Multilineage potential of adult human mesenchymal stem cells. Science (1999) 66.19
Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol (2007) 21.93
Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell (1997) 18.91
Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell (1997) 16.78
Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell (2010) 15.58
The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell (2002) 15.20
Induction of human neuronal cells by defined transcription factors. Nature (2011) 6.84
Strategies and new developments in the generation of patient-specific pluripotent stem cells. Cell Stem Cell (2007) 6.62
Direct conversion of mouse fibroblasts to hepatocyte-like cells by defined factors. Nature (2011) 5.84
Osteoporosis: now and the future. Lancet (2011) 5.81
Direct conversion of human fibroblasts to multilineage blood progenitors. Nature (2010) 5.35
Induction of functional hepatocyte-like cells from mouse fibroblasts by defined factors. Nature (2011) 5.28
Direct reprogramming of fibroblasts into neural stem cells by defined factors. Cell Stem Cell (2012) 4.28
Direct conversion of fibroblasts into stably expandable neural stem cells. Cell Stem Cell (2012) 3.52
Reprogramming of human fibroblasts toward a cardiac fate. Proc Natl Acad Sci U S A (2013) 3.14
Age-related intrinsic changes in human bone-marrow-derived mesenchymal stem cells and their differentiation to osteoblasts. Aging Cell (2008) 3.08
Epigenetic modifications in pluripotent and differentiated cells. Nat Biotechnol (2010) 3.02
Regulation of osteoblast differentiation by transcription factors. J Cell Biochem (2006) 2.86
Induction of pluripotency in mouse somatic cells with lineage specifiers. Cell (2013) 2.69
Promotion of direct reprogramming by transformation-deficient Myc. Proc Natl Acad Sci U S A (2010) 2.44
Regulation of bone development and extracellular matrix protein genes by RUNX2. Cell Tissue Res (2009) 2.41
Relationship between donor age and the replicative lifespan of human cells in culture: a reevaluation. Proc Natl Acad Sci U S A (1998) 2.36
Hayflick, his limit, and cellular ageing. Nat Rev Mol Cell Biol (2000) 2.15
Cooperative interactions between activating transcription factor 4 and Runx2/Cbfa1 stimulate osteoblast-specific osteocalcin gene expression. J Biol Chem (2005) 1.91
Induction of human cardiomyocyte-like cells from fibroblasts by defined factors. Proc Natl Acad Sci U S A (2013) 1.74
Osteoblast physiology in normal and pathological conditions. Cell Tissue Res (2010) 1.49
Generation of hyaline cartilaginous tissue from mouse adult dermal fibroblast culture by defined factors. J Clin Invest (2011) 1.45
Reprogramming to pluripotency: stepwise resetting of the epigenetic landscape. Cell Res (2011) 1.41
Mechanotransduction in osteoblast regulation and bone disease. Trends Mol Med (2009) 1.32
Mechanisms and control of pathologic bone loss in periodontitis. Periodontol 2000 (2010) 1.26
Genetic and molecular control of osterix in skeletal formation. J Cell Biochem (2013) 1.19
Age-related alterations in mesenchymal stem cells related to shift in differentiation from osteogenic to adipogenic potential: implication to age-associated bone diseases and defects. Mech Ageing Dev (2012) 1.13
Efficient adipocyte and osteoblast differentiation from mouse induced pluripotent stem cells by adenoviral transduction. Stem Cells (2009) 1.12
Reduced CpG methylation is associated with transcriptional activation of the bone-specific rat osteocalcin gene in osteoblasts. J Cell Biochem (2002) 1.09
Direct lineage reprogramming to neural cells. Curr Opin Neurobiol (2012) 1.08
Transcription factor Runx2 and its application to bone tissue engineering. Stem Cell Rev (2012) 1.05
Direct reprogramming of mouse fibroblasts into cardiac myocytes. J Cardiovasc Transl Res (2012) 0.98
Therapeutic application of mesenchymal stem cells in bone and joint diseases. Clin Exp Med (2012) 0.93
Overexpression of Runx2 and MKP-1 stimulates transdifferentiation of 3T3-L1 preadipocytes into bone-forming osteoblasts in vitro. Calcif Tissue Int (2011) 0.88
Dermal fibroblasts genetically modified to express Runx2/Cbfa1 as a mineralizing cell source for bone tissue engineering. Tissue Eng (2007) 0.88
Enhanced isolation of fibroblasts from human skin explants. Biotechniques (2012) 0.86
Hematopoietic cell regulation of osteoblast proliferation and differentiation. Curr Osteoporos Rep (2011) 0.85
Soluble rank ligand produced by myeloma cells causes generalised bone loss in multiple myeloma. PLoS One (2012) 0.85